ROBERT LANGER - 17 Aug 2022 Form 4 Insider Report for Frequency Therapeutics, Inc. (KRRO)

Role
Director
Signature
/s/ James P. Abely, Attorney-in-Fact for Robert S. Langer
Issuer symbol
KRRO
Transactions as of
17 Aug 2022
Net transactions value
$0
Form type
4
Filing time
19 Aug 2022, 16:07:28 UTC
Previous filing
23 Jun 2022
Next filing
03 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FREQ Stock Option Award +14,846 14,846 17 Aug 2022 Common Stock 14,846 $2.14 Direct F1, F2
transaction FREQ Stock Option Disposed to Issuer -14,846 -100% 0 17 Aug 2022 Common Stock 14,846 $18.63 Direct F2, F3
transaction FREQ Stock Option Award +14,846 14,846 17 Aug 2022 Common Stock 14,846 $2.14 Direct F2, F4
transaction FREQ Stock Option Disposed to Issuer -14,846 -100% 0 17 Aug 2022 Common Stock 14,846 $10.14 Direct F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vested in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders.
F2 The transaction reported herein reflects a one-time stock option repricing that became effective on August 17, 2022 and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these options.
F3 The option vests in full on the earlier of June 11, 2021 or the day immediately prior to the company's 2021 annual meeting of shareholders.
F4 The option vested in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.
F5 The option vests in full on the earlier of June 17, 2022 or the day immediately prior to the company's 2022 annual meeting of shareholders.